WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year
WuXi AppTec has been awarded the 2024 Global CRDMO Company of the Year Award by Frost & Sullivan for the eighth consecutive year. The recognition highlights the company's excellence in providing integrated contract research, development, and manufacturing services to pharmaceutical and life science industries. The award acknowledges WuXi AppTec's commitment to quality standards, innovation, and ability to help customers accelerate development while managing costs effectively. The company's CRDMO model offers comprehensive support from discovery to commercialization, enabling customers to deliver groundbreaking treatments to patients worldwide.
WuXi AppTec è stata premiata con il Premio Mondiale CRDMO dell'Anno 2024 da Frost & Sullivan per l'ottavo anno consecutivo. Questo riconoscimento mette in evidenza l'eccellenza dell'azienda nella fornitura di servizi integrati di ricerca contrattuale, sviluppo e produzione per le industrie farmaceutiche e delle scienze della vita. Il premio riconosce l'impegno di WuXi AppTec per gli standard di qualità, l'innovazione e la capacità di aiutare i clienti ad accelerare lo sviluppo, gestendo al contempo efficacemente i costi. Il modello CRDMO dell'azienda offre supporto completo dalla scoperta alla commercializzazione, consentendo ai clienti di fornire trattamenti innovativi ai pazienti in tutto il mondo.
WuXi AppTec ha sido galardonada con el Premio Global CRDMO de la Empresa del Año 2024 por Frost & Sullivan durante el octavo año consecutivo. Este reconocimiento destaca la excelencia de la compañía en la provisión de servicios integrados de investigación, desarrollo y fabricación para las industrias farmacéuticas y de ciencias de la vida. El premio reconoce el compromiso de WuXi AppTec con los estándares de calidad, la innovación y la capacidad de ayudar a los clientes a acelerar el desarrollo mientras gestionan los costos de manera efectiva. El modelo CRDMO de la empresa ofrece un apoyo integral desde el descubrimiento hasta la comercialización, permitiendo a los clientes ofrecer tratamientos innovadores a pacientes en todo el mundo.
우시 앱텍은 프로스트 앤드 설리번(Frost & Sullivan)으로부터 2024 글로벌 CRDMO 올해의 기업 상을 8년 연속 수상하였습니다. 이 인식은 제약 및 생명 과학 산업에 통합 계약 연구, 개발 및 제조 서비스를 제공하는 회사의 우수성을 강조합니다. 이 상은 품질 기준, 혁신에 대한 우시 앱텍의 헌신과 비용을 효과적으로 관리하면서 고객이 개발을 가속화하도록 돕는 능력을 인정합니다. 회사의 CRDMO 모델은 발견에서 상용화까지의 포괄적인 지원을 제공하여 고객이 전 세계 환자에게 획기적인 치료법을 제공할 수 있도록 합니다.
WuXi AppTec a été récompensée par le Prix Mondial CRDMO de l'Entreprise de l'Année 2024 par Frost & Sullivan pour la huitième année consécutive. Cette reconnaissance met en avant l'excellence de l'entreprise dans la fourniture de services intégrés de recherche, de développement et de fabrication pour les industries pharmaceutiques et des sciences de la vie. Le prix reconnaît l'engagement de WuXi AppTec envers les normes de qualité, l'innovation et sa capacité à aider les clients à accélérer le développement tout en gérant efficacement les coûts. Le modèle CRDMO de l'entreprise offre un soutien complet, de la découverte à la commercialisation, permettant ainsi aux clients d'apporter des traitements révolutionnaires aux patients du monde entier.
WuXi AppTec wurde zum 2024 Global CRDMO Company of the Year Award von Frost & Sullivan für das achte Jahr in Folge ausgezeichnet. Diese Auszeichnung hebt die Exzellenz des Unternehmens bei der Bereitstellung integrierter Vertragsforschungs-, Entwicklungs- und Fertigungsdienste für die pharmazeutische Industrie und die Lebenswissenschaften hervor. Der Preis anerkennt WuXi AppTecs Engagement für Qualitätsstandards, Innovation und die Fähigkeit, Kunden bei der beschleunigten Entwicklung zu unterstützen, während die Kosten effektiv verwaltet werden. Das CRDMO-Modell des Unternehmens bietet umfassende Unterstützung von der Entdeckung bis zur Kommerzialisierung, sodass Kunden bahnbrechende Behandlungen weltweit an Patienten liefern können.
- Received prestigious industry award for 8th consecutive year, demonstrating sustained market leadership
- Integrated CRDMO model enables cost efficiency and accelerated development for customers
- Strong market position in supporting pharmaceutical and biotech development
- None.
This recognition underscores WuXi AppTec's enduring commitment to addressing customers' needs with its unique contract research, development, and manufacturing organization (CRDMO) model. From discovery to commercialization, WuXi AppTec's CRDMO model provides our customers with the highest quality standards and seamless support throughout the drug development process. Additionally, Frost & Sullivan commends the company for driving innovation, adhering to the highest quality standards, and helping customers accelerate development, improve productivity, and manage costs effectively.
"We are delighted to receive the 2024 Global CRDMO Company of the Year Award from Frost & Sullivan," said Dr. Ge Li, Chairman and CEO of WuXi AppTec. "WuXi AppTec is committed to enhancing our unique integrated CRDMO business model to foster collaboration and drive innovation. Our customers deliver groundbreaking treatments to patients around the world, and we are honored to continue supporting these efforts with the highest quality standards and service."
"Frost & Sullivan is impressed by WuXi AppTec's proactive approach to addressing evolving pharma and biotech needs through its unique CRDMO business model, which enables the company to foster scientific innovation, develop distinct industry insights, and leverage opportunities in new molecules," said Ojaswi Rana, a research analyst at Frost & Sullivan. "By continuously enhancing its capabilities and capacity, the company supports the industry and customers to bring groundbreaking therapies to patients around the world."
Frost & Sullivan reserves this recognition for companies at the forefront of innovation and growth in their respective industries, innovating and creating new products, solutions, and services that meet ever-evolving customer needs.
About WuXi AppTec
As a global company with operations across
View original content:https://www.prnewswire.com/news-releases/wuxi-apptec-named-global-crdmo-company-of-the-year-by-frost--sullivan-for-the-eighth-consecutive-year-302289861.html
SOURCE WuXi AppTec
FAQ
What award did WuXi AppTec (WUXAY) receive in 2024?
How many consecutive years has WuXi AppTec (WUXAY) won the Frost & Sullivan CRDMO Award?
What services does WuXi AppTec (WUXAY) provide as a CRDMO?
